Asia-Pacific Heart Failure Therapeutics Market 2019 - Industry Key Trends, Growth Prospects and Forecasts to 2024
Researchmoz added Most up-to-date research on "Heart Failure Therapeutics in Asia-Pacific Markets to 2024 - Growth Driven by Rising Geriatric Population and Increasing Uptake of Recently Launched Therapy" to its huge collection of research reports. Heart failure (HF) is a life-threatening syndrome with substantial morbidity and mortality. There are more than 26 million people with HF globally and this is increasing because of the rapidly aging population. HF is a major global healthcare problem as the number of HF patients is increasing. It has the greatest negative impact on quality of life compared with other major chronic disease, such as diabetes, arthritis, and hypertension. Get Complimentary Research Summary of the Report: https://www.researchmoz.us/enquiry.php?type=S&repid=1915182 HF has been gradually rising in the Asia-Pacific region, with the growing elderly population and increasingly Westernized lifestyles. Increasing risk factors will result in an increased ...